Works matching IS 03065251 AND DT 1992 AND VI 34 AND IP 2
1
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 144, doi. 10.1111/j.1365-2125.1992.tb04123.x
- Article
2
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 96, doi. 10.1111/j.1365-2125.1992.tb04116.x
- Article
3
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 139, doi. 10.1111/j.1365-2125.1992.tb04122.x
- Challier, JC;
- Rey, E;
- Bintein, T;
- Olive, G
- Article
4
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 115, doi. 10.1111/j.1365-2125.1992.tb04119.x
- MacFadyen, RJ;
- Lees, KR;
- Reid, JL
- Article
5
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 130, doi. 10.1111/j.1365-2125.1992.tb04121.x
- Osborne, R;
- Thompson, P;
- Joel, S;
- Trew, D;
- Patel, N;
- Slevin, M
- Article
6
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 106, doi. 10.1111/j.1365-2125.1992.tb04118.x
- Article
7
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 122, doi. 10.1111/j.1365-2125.1992.tb04120.x
- Bauer, KG;
- Brunner-Ferber, F;
- Distlerath, LM;
- Lippa, EA;
- Binkowitz, B;
- Till, P;
- Kaik, GA
- Article
8
- British Journal of Clinical Pharmacology, 1992, v. 34, n. 2, p. 102, doi. 10.1111/j.1365-2125.1992.tb04117.x
- Connell, JM;
- Jardine, AG;
- Northridge, DB
- Article